The World Health Organisation (WHO) announced this morning the recommended composition of influenza vaccines for the upcoming northern hemisphere influenza season 2014 to 15.
This recommendation follows a three-day consultation involving a core group of global influenza organisations and regulators. One of the main UK representatives is the WHO Essential Regulatory Laboratory (ERL) at NIBSC.
NIBSC played a key role in providing analysis to the WHO consultation and continues its vital role in the global influenza vaccine production cycle.
Find out more in the influenza news section of the website.